InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Accounts Payables (2016 - 2026)

InflaRx's (IFRX) quarterly Accounts Payables came in at $6.2 million in Q2 2026, down 100.0% year-over-year from $11020.4 billion in Q2 2025, and up 8.68% quarter-over-quarter from $5.7 million in Q1 2026.

Analysis

InflaRx (IFRX) Accounts Payables (2016 - 2026) Analysis & Trends

InflaRx has disclosed Accounts Payables across 11 years of filings, most recently posting $6.2 million for Q2 2026.

  • In Q2 2026, Accounts Payables fell 100.0% year-over-year to $6.2 million; the TTM figure through Jun 2026 stood at $6.2 million (down 100.0% YoY), while the FY2025 annual figure was $6.1 million, down 100.0% from the prior year.
  • Accounts Payables came in at $6.2 million for Q2 2026 at InflaRx, up from $5.7 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $12175.8 billion in Q4 2024 to a low of $5.0 million in Q1 2023.
  • Average Accounts Payables over 5 years is $1288.7 billion, with a median of $8.4 million recorded in 2022.
  • The largest YoY upside for Accounts Payables was 119761813.95% in 2025 against a maximum downside of 100.0% in 2025.
  • Over 5 years, Accounts Payables stood at $5.1 million in 2022, then surged by 153.19% to $12.9 million in 2023, then jumped by 94505590.22% to $12175.8 billion in 2024, then plunged by 100.0% to $6.3 million in 2025, then decreased by 1.91% to $6.2 million in 2026.
  • Per Business Quant data, the three most recent Accounts Payables figures were $6.2 million in Q2 2026, $5.7 million in Q1 2026, and $6.3 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 2.87 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 674.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 429.50 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.16 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.52 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 167.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 108.02 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 403.90 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 25.08 Mn
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn 6.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.17 Mn
Mar 31, 2026 5.67 Mn
Dec 31, 2025 6.29 Mn
Sep 30, 2025 10.79 Mn
Jun 30, 2025 11,020.37 Bn
Mar 31, 2025 8.80 Mn
Dec 31, 2024 12,175.82 Bn
Sep 30, 2024 12.87 Mn
Jun 30, 2024 9.20 Mn
Mar 31, 2024 8.26 Mn
Dec 31, 2023 12.88 Mn
Sep 30, 2023 6.53 Mn
Jun 30, 2023 5.66 Mn
Mar 31, 2023 4.95 Mn
Dec 31, 2022 5.09 Mn
Sep 30, 2022 7.50 Mn
Jun 30, 2022 8.44 Mn
Mar 31, 2022 10.67 Mn
Dec 31, 2021 9.81 Mn
Sep 30, 2021 13.58 Mn